Alf Meem Yaa for Medical Supplies and Equipment Company (TADAWUL: 9527)
Saudi Arabia
· Delayed Price · Currency is SAR
97.60
-1.30 (-1.31%)
Nov 21, 2024, 12:17 PM AST
Alf Meem Yaa for Medical Supplies and Equipment Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 236.8 | 223.32 | 193.17 | 151.39 | 121.6 | 89.92 |
Revenue Growth (YoY) | 15.42% | 15.61% | 27.60% | 24.49% | 35.23% | - |
Cost of Revenue | 135.19 | 124.57 | 102.89 | 81.84 | 66.32 | 48.15 |
Gross Profit | 101.61 | 98.75 | 90.28 | 69.54 | 55.28 | 41.77 |
Selling, General & Admin | 59.43 | 56.56 | 52.68 | 40.38 | 29.09 | 25.99 |
Other Operating Expenses | -1.22 | -0.8 | - | 4.45 | - | - |
Operating Expenses | 60.59 | 61.91 | 60.55 | 45.11 | 32.64 | 25.45 |
Operating Income | 41.02 | 36.84 | 29.73 | 24.44 | 22.64 | 16.32 |
Interest Expense | -0.19 | -0.21 | -0.1 | -0.17 | -0.07 | -0.01 |
Currency Exchange Gain (Loss) | 0.95 | 0.95 | 0.41 | -0.06 | - | - |
Pretax Income | 42 | 37.58 | 30.03 | 24.21 | 22.57 | 16.31 |
Income Tax Expense | 4.09 | 4.07 | 3.35 | 2.99 | 1.5 | 1.5 |
Net Income | 37.91 | 33.52 | 26.68 | 21.22 | 21.07 | 14.81 |
Net Income to Common | 37.91 | 33.52 | 26.68 | 21.22 | 21.07 | 14.81 |
Net Income Growth | 13.16% | 25.60% | 25.73% | 0.72% | 42.27% | - |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 6 | 1 |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 6 | 1 |
Shares Change (YoY) | - | - | 0.65% | 21.22% | 1047.52% | - |
EPS (Basic) | 5.42 | 4.79 | 3.81 | 3.05 | 3.67 | 29.62 |
EPS (Diluted) | 5.42 | 4.79 | 3.81 | 3.05 | 3.67 | 29.62 |
EPS Growth | 13.16% | 25.60% | 24.93% | -16.91% | -87.60% | - |
Free Cash Flow | -2.51 | 34.72 | 7.56 | 19.93 | 2.45 | 10.8 |
Free Cash Flow Per Share | -0.36 | 4.96 | 1.08 | 2.87 | 0.43 | 21.61 |
Dividend Per Share | 2.000 | 2.000 | 2.000 | 1.750 | - | - |
Dividend Growth | 0% | 0% | 14.29% | - | - | - |
Gross Margin | 42.91% | 44.22% | 46.74% | 45.94% | 45.46% | 46.45% |
Operating Margin | 17.32% | 16.50% | 15.39% | 16.14% | 18.62% | 18.15% |
Profit Margin | 16.01% | 15.01% | 13.81% | 14.02% | 17.33% | 16.47% |
Free Cash Flow Margin | -1.06% | 15.55% | 3.91% | 13.16% | 2.02% | 12.01% |
EBITDA | 41.61 | 37.26 | 30.01 | 24.56 | 22.76 | 16.37 |
EBITDA Margin | 17.57% | 16.68% | 15.54% | 16.22% | 18.72% | 18.21% |
D&A For EBITDA | 0.59 | 0.42 | 0.28 | 0.12 | 0.12 | 0.05 |
EBIT | 41.02 | 36.84 | 29.73 | 24.44 | 22.64 | 16.32 |
EBIT Margin | 17.32% | 16.50% | 15.39% | 16.14% | 18.62% | 18.15% |
Effective Tax Rate | 9.74% | 10.82% | 11.15% | 12.34% | 6.65% | 9.20% |
Source: S&P Capital IQ. Standard template.
Financial Sources.